1 results match your criteria: "Infectious Diseases Centre of Excellence in Drug Discovery (ID CEDD)[Affiliation]"
Toxicol In Vitro
December 2009
GlaxoSmithKline, Diseases of the Developing World Centre (DDW), Infectious Diseases Centre of Excellence in Drug Discovery (ID CEDD), Tres Cantos, Spain.
Drug-induced phospholipidosis (PLD) is characterized by the excessive accumulation of phospholipids in lysosomes. It is accompanied by intracellular retention of drug that could be associated with increased cytotoxicity. Drug-induced PLD is recognized as a significant challenge for drug development, depending on the severity of the effect it could be reversible or caused cell death.
View Article and Find Full Text PDF